S&P 500   2,987.39 (+0.72%)
DOW   26,978.96 (+0.72%)
QQQ   192.62 (+0.80%)
MSFT   140.88 (+0.95%)
GOOGL   1,232.18 (+1.18%)
AMZN   1,746.61 (+0.59%)
CGC   20.14 (+6.79%)
NVDA   193.33 (+3.65%)
MU   45.47 (+1.36%)
GE   8.67 (-0.69%)
TSLA   256.70 (-0.10%)
AMD   30.47 (-0.20%)
F   8.93 (+1.25%)
ACB   3.77 (+7.41%)
PRI   121.90 (+0.35%)
NFLX   283.06 (-0.87%)
BAC   29.36 (+0.75%)
DIS   129.51 (-0.15%)
S&P 500   2,987.39 (+0.72%)
DOW   26,978.96 (+0.72%)
QQQ   192.62 (+0.80%)
MSFT   140.88 (+0.95%)
GOOGL   1,232.18 (+1.18%)
AMZN   1,746.61 (+0.59%)
CGC   20.14 (+6.79%)
NVDA   193.33 (+3.65%)
MU   45.47 (+1.36%)
GE   8.67 (-0.69%)
TSLA   256.70 (-0.10%)
AMD   30.47 (-0.20%)
F   8.93 (+1.25%)
ACB   3.77 (+7.41%)
PRI   121.90 (+0.35%)
NFLX   283.06 (-0.87%)
BAC   29.36 (+0.75%)
DIS   129.51 (-0.15%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Acer TherapeuticsVital TherapiesSierra OncologyBio-PathLeap Therapeutics
SymbolNASDAQ:ACERN/ANASDAQ:SRRANASDAQ:BPTHNASDAQ:LPTX
Price Information
Current Price$2.97N/A$0.32$10.65$1.15
52 Week RangeHoldN/ABuyBuyBuy
Analyst Ratings
Consensus RecommendationHoldN/ABuyBuyBuy
Consensus Price Target$31.00N/AN/A$28.00$9.00
% Upside from Price Target943.77% upsideN/AN/A162.91% upside682.61% upside
Trade Information
Market Cap$29.09 million$35.17 million$24.20 million$27.86 million$27.41 million
Beta1.533.511.283.212.47
Average Volume70,44021,618,420430,94448,096246,272
Sales & Book Value
Annual Revenue$2.90 millionN/AN/A$40,000.00N/A
Price / Sales10.34N/AN/A766.80N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$4.64 per share$0.29 per share$1.27 per share$1.79 per share$0.62 per share
Price / Book0.64N/AN/A5.95N/A
Profitability
Net Income$-21,280,000.00$-41,470,000.00$-53,330,000.00$-8,580,000.00$-23,140,000.00
EPS($2.49)N/A($0.75)($14.38)($2.51)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)-76.99%-235.33%-64.97%-84.81%-297.79%
Return on Assets (ROA)-70.04%-182.35%-56.38%-76.39%-141.13%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.06%0.02%0.07%
Current Ratio4.92%6.97%9.24%18.01%1.99%
Quick Ratio4.92%6.97%9.24%18.01%1.99%
Ownership Information
Institutional Ownership Percentage24.44%15.52%52.28%9.48%10.84%
Insider Ownership Percentage20.10%33.90%6.81%8.65%36.10%
Miscellaneous
Employees231079823
Shares Outstanding10.10 million42.37 million74.69 million2.88 million24.04 million
Next Earnings Date11/8/2019 (Estimated)N/A11/14/2019 (Estimated)11/21/2019 (Estimated)11/8/2019 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableNot Optionable
 Acer TherapeuticsVital TherapiesSierra OncologyBio-PathLeap Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel